Related Experiment Video
Updated: Jun 7, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation
Kohki Kawane1, Hiromi Tanaka, Yusuke Kitahara
1Department of Medical Chemistry, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
Abstract:
DNase II digests the chromosomal DNA in macrophages after apoptotic cells and nuclei from erythroid precursors are engulfed. The DNase II-null mice develop a polyarthritis that resembles rheumatoid arthritis. Here, we showed that when bone marrow cells from the DNase II-deficient mice were transferred to the wild-type mice, they developed arthritis. A deficiency of Rag2 or a lack of lymphocytes accelerated arthritis of the DNase II-null mice, suggesting that the DNase II(-/-) macrophages were responsible for triggering arthritis, and their lymphocytes worked protectively. A high level of TNFα, IL-1β, and IL-6 was found in the affected joints of the DNase II-null mice, suggesting an inflammatory-skewed cytokine storm was established in the joints. A lack of TNFα, IL-1β, or IL-6 gene blocked the expression of the other cytokine genes as well and inhibited the development of arthritis. Neutralization of TNFα, IL-1β, or IL-6 had a therapeutic effect on the developed arthritis of the DNase II-null mice, indicating that the cytokine storm was essential for the maintenance of arthritis in the DNase II-deficient mice. Methotrexate, an antimetabolite that is often used to treat patients with rheumatoid arthritis, had a therapeutic effect with the DNase II-null mice. These properties of arthritis in the DNase II-null mice were similar to those found in human systemic-onset juvenile idiopathic arthritis or Still's disease, indicating that the DNase II-null mice are a good animal model of this type of arthritis.
Insights
DNase II deficiency in macrophages triggers polyarthritis resembling rheumatoid arthritis in mice. This inflammatory condition, driven by a cytokine storm, shows promise as a model for human Still's disease.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- DNase II is crucial for digesting DNA in macrophages after engulfing apoptotic cells.
- DNase II-null mice spontaneously develop polyarthritis, mimicking rheumatoid arthritis.
Purpose of the Study:
- To investigate the role of DNase II deficiency in arthritis development.
- To elucidate the mechanisms underlying the inflammatory processes in DNase II-null mice.
- To evaluate the potential of DNase II-null mice as a model for human inflammatory arthritis.
Main Methods:
- Bone marrow transplantation from DNase II-deficient to wild-type mice.
- Genetic manipulation (Rag2 deficiency, cytokine gene knockout).
- Cytokine neutralization and pharmacological treatment (methotrexate).
Main Results:
- DNase II-deficient macrophages, not lymphocytes, initiate arthritis.
- Arthritis development is associated with a cytokine storm (TNFα, IL-1β, IL-6) in affected joints.
- Blocking key cytokines or using methotrexate ameliorates arthritis in DNase II-null mice.
Conclusions:
- DNase II deficiency leads to a lymphocyte-independent, macrophage-driven autoimmune arthritis.
- The cytokine storm is essential for arthritis pathogenesis in DNase II-null mice.
- DNase II-null mice represent a valuable preclinical model for human systemic-onset juvenile idiopathic arthritis (Still's disease).
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Inflammatory Bowel Disease III: Crohn's Disease
Other Unique Bacteria
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
